Windtree Therapeutics, Inc.
WINT
$0.05
$0.00-5.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.21M | 8.12M | 7.91M | 8.24M | 8.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.75M | 16.74M | 24.20M | 24.52M | 25.36M |
| Operating Income | -15.75M | -16.74M | -24.20M | -24.52M | -25.36M |
| Income Before Tax | -43.50M | -14.98M | -16.17M | -1.79M | -9.64M |
| Income Tax Expenses | -3.51M | -317.00K | -120.00K | -6.00K | 71.00K |
| Earnings from Continuing Operations | -39.99 | -14.66 | -16.05 | -1.79 | -9.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.99M | -14.66M | -16.05M | -1.79M | -9.71M |
| EBIT | -15.75M | -16.74M | -24.20M | -24.52M | -25.36M |
| EBITDA | -15.33M | -16.66M | -24.12M | -24.43M | -25.27M |
| EPS Basic | -8.38 | -218.68 | -1.26K | -1.26K | -1.26K |
| Normalized Basic EPS | 12.20 | -95.24 | -736.81 | -734.50 | -750.75 |
| EPS Diluted | -8.38 | -218.68 | -1.26K | -1.26K | -1.26K |
| Normalized Diluted EPS | 12.20 | -95.24 | -736.81 | -734.50 | -750.75 |
| Average Basic Shares Outstanding | 32.81M | 6.16M | 1.29M | 201.00K | 29.20K |
| Average Diluted Shares Outstanding | 32.81M | 6.16M | 1.29M | 201.00K | 29.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.00% | -5.10% | -4.65% | -36.77% | -3.57% |